Search Results - David L. Rimm

Refine Results
  1. 1

    Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization by Jason A. Hanna, Hallie Wimberly, Salil Kumar, Frank Slack, Seema Agarwal, David L. Rimm

    Published in BioTechniques (2012-04-01)
    Get full text
    Article


  2. 2

    Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry by Tyler MacNeil, Ioannis A Vathiotis, Sandra Martinez-Morilla, Vesal Yaghoobi, Jon Zugazagoitia, Yuting Liu, David L Rimm

    Published in BioTechniques (2020-12-01)
    Get full text
    Article


  3. 3

    Antibody validation by Jennifer Bordeaux, Allison W. Welsh, Seema Agarwal, Elizabeth Killiam, Maria T. Baquero, Jason A. Hanna, Valsamo K. Anagnostou, David L. Rimm

    Published in BioTechniques (2010-03-01)
    Get full text
    Article


  4. 4

    Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers by Brian Alexander, Lajos Pusztai, David L Rimm, Priti Hegde, Mariya Rozenblit, Richard Huang, Natalie Danziger, Shakti Ramkissoon, Kim Blenman, Jeffrey S Ross

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  5. 5

    BCAM (basal cell adhesion molecule) protein expression in different tumor populations by Sneha Burela, Mengni He, Ioannis P. Trontzas, Niki Gavrielatou, Kurt A. Schalper, Solomon Langermann, Dallas B. Flies, David L. Rimm, Thazin N. Aung

    Published in Discover Oncology (2024-08-01)
    Get full text
    Article


  6. 6

    The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Research in context by Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Nimeus, Roberto Salgado, Yalai Bai, David L. Rimm, Johan Hartman, Balazs Acs

    Published in EClinicalMedicine (2024-12-01)
    Get full text
    Article


  7. 7

    Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance by David A. Schoenfeld, Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar, Lucia Jilaveanu, Michael Hurwitz, David L. Rimm, Harriet M. Kluger

    Published in Frontiers in Oncology (2022-10-01)
    Get full text
    Article


  8. 8

    Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance by Vasiliki Pelekanou, Daniel E. Carvajal-Hausdorf, Mehmet Altan, Brad Wasserman, Cristobal Carvajal-Hausdorf, Hallie Wimberly, Jason Brown, Donald Lannin, Lajos Pusztai, David L. Rimm

    Published in Breast Cancer Research (2017-09-01)
    Get full text
    Article


  9. 9

    Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review by Taja Lozar, Wei Wang, Niki Gavrielatou, Leslie Christensen, Paul F. Lambert, Paul M. Harari, David L. Rimm, Barbara Burtness, Cvetka Grasic Kuhar, Evie H. Carchman

    Published in Viruses (2023-11-01)
    Get full text
    Article


  10. 10

    [Letter to the Editor] The need for improved education and training in research antibody usage and validation practices by Leonard P. Freedman, Mark C. Gibson, Andrew R.M. Bradbury, Arthur M. Buchberg, Darryl Davis, Marisa P. Dolled-Filhart, Fridtjof Lund-Johansen, David L. Rimm

    Published in BioTechniques (2016-07-01)
    Get full text
    Article


  11. 11

    Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality by Ioannis A. Vathiotis, Zhi Yang, Jason Reeves, Maria Toki, Thazin Nwe Aung, Pok Fai Wong, Harriet Kluger, Konstantinos N. Syrigos, Sarah Warren, David L. Rimm

    Published in npj Precision Oncology (2021-05-01)
    Get full text
    Article


  12. 12

    Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma by Mario Sznol, Harriet M. Kluger, Pok Fai Wong, James W. Smithy, David L. Rimm, Vasiliki Pelekanou, Lauren M. Moore, Jamaal Rehman, Patricia Gaule, Veronique M. Neumeister

    Published in Journal for ImmunoTherapy of Cancer (2017-12-01)
    Get full text
    Article


  13. 13

    Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors by Christina M. Dieli-Conwright, Maura Harrigan, Brenda Cartmel, Anees Chagpar, Yalai Bai, Fang-yong Li, David L. Rimm, Lajos Pusztai, Lingeng Lu, Tara Sanft, Melinda L. Irwin

    Published in npj Breast Cancer (2022-03-01)
    Get full text
    Article


  14. 14

    Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy by Sandra Martinez-Morilla, Myrto Moutafi, Aileen I. Fernandez, Shlomit Jessel, Prajan Divakar, Pok Fai Wong, Rolando Garcia-Milian, Kurt A. Schalper, Harriet M. Kluger, David L. Rimm

    Published in OncoImmunology (2023-12-01)
    Get full text
    Article


  15. 15

    An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma by Balazs Acs, Fahad Shabbir Ahmed, Swati Gupta, Pok Fai Wong, Robyn D. Gartrell, Jaya Sarin Pradhan, Emanuelle M. Rizk, Bonnie Gould Rothberg, Yvonne M. Saenger, David L. Rimm

    Published in Nature Communications (2019-11-01)
    Get full text
    Article


  16. 16

    High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC) by David L Rimm, Kurt A Schalper, Myrto K Moutafi, Ioannis A Vathiotis, Niki Gavrielatou, Katherine M Bates, Thazin Nwe Aung, Rolando Garcia Milian, Vasiliki Xirou, Athanasios Angelakis, Leonidas Salichos

    Published in Journal for ImmunoTherapy of Cancer (2024-06-01)
    Get full text
    Article


  17. 17

    Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer by Roy S Herbst, Lieping Chen, David L Rimm, Miguel F Sanmamed, Kurt A Schalper, Alice Li, Konstantinos Syrigos, Jovian Yu, Adam Aguirre-Ducler, Brian S Henick, Franz Villarroel-Espindola, Ila Datar, Shruti Desai

    Published in Journal for ImmunoTherapy of Cancer (2022-07-01)
    Get full text
    Article


  18. 18

    Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma by Ruth Halaban, Kelly Olino, James Clune, David L Rimm, Harriet M Kluger, Dijana Djureinovic, Wael Ibrahim, Raymond Baumann, Anjela Galan, David G Su, David A. Schoenfeld, Raysa Cabrejo, Sajid A Khan

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Get full text
    Article


  19. 19

    Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade by Ioannis A. Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M. Kluger, Konstantinos N. Syrigos, Sarah Warren, Mark Gerstein, David L. Rimm

    Published in npj Precision Oncology (2022-12-01)
    Get full text
    Article


  20. 20

    Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study by Vesal Yaghoobi, Myrto Moutafi, Thazin Nwe Aung, Vasiliki Pelekanou, Sanam Yaghoubi, Kim Blenman, Eiman Ibrahim, Ioannis A. Vathiotis, Saba Shafi, Anup Sharma, Tess O’Meara, Aileen I. Fernandez, Lajos Pusztai, David L. Rimm

    Published in Breast Cancer Research (2021-12-01)
    Get full text
    Article


Search Tools: